Focus
exa-cel treatment
LATEST
FDA Document Raises Concerns Over a New Gene Editing Therapy
A cutting-edge cure or CRISPR catastrophe? That’s the question facing regulators.
|
FDA Document Raises Concerns Over a New Gene Editing Therapy
A cutting-edge cure or CRISPR catastrophe? That’s the question facing regulators.
|